Canada approves GSK’s Arexvy vaccine for RSV protection in adults 50-59 at elevated risk

Pallavi Madhiraju- November 7, 2024 0

In a crucial development for public health, Health Canada has extended its approval for GlaxoSmithKline's Arexvy vaccine to include adults aged 50 to 59 who ... Read More

Clinuvel Pharmaceuticals submits NDA for SCENESSE to Health Canada, aiming to treat rare genetic disorder

Pallavi Madhiraju- October 1, 2024 0

Clinuvel Pharmaceuticals has filed a New Drug Submission to Health Canada for its innovative therapy, SCENESSE, marking a potential breakthrough for Canadian patients suffering from ... Read More

Health Canada approves KEYTRUDA and Enfortumab Vedotin for advanced urothelial cancer

Pallavi Madhiraju- August 22, 2024 0

Merck (NYSE: MRK), known as MSD outside the United States and Canada, has announced that Health Canada has granted approval for KEYTRUDA (pembrolizumab) in combination ... Read More

Revolutionizing diabetes care: Dexcom G7 CGM System gets Health Canada nod

Pallavi Madhiraju- July 4, 2023 0

Dexcom, a notable player in real-time continuous glucose monitoring (rtCGM) globally, confirmed today that Health Canada has given its approval for the next-generation Dexcom G7 ... Read More

Sun Pharma gains Health Canada’s approval for WINLEVI for acne treatment

Pallavi Madhiraju- June 19, 2023 0

Sun Pharma Canada, a subsidiary of Sun Pharmaceutical Industries, has secured Health Canada's approval for their pioneering acne treatment, WINLEVI (clascoterone cream 1%). This marks ... Read More

Lupin gets Health Canada approval for generic Spiriva for COPD treatment

Pallavi Madhiraju- May 27, 2023 0

Lupin has announced that its subsidiary in Canada, Lupin Pharma Canada has received approval from Health Canada to market a generic version of Spiriva (tiotropium ... Read More

Lupin secures Health Canada approval for Enbrel biosimilar – Rymti

pallavi123- September 13, 2022 0

Lupin Limited has secured approval from Health Canada for Rymti, the company’s biosimilar to Enbrel (etanercept), an inhibitor of tumour necrosis factor (TNF). Rymti is ... Read More

Natco Pharma launches PrNAT-LENALIDOMIDE Capsules in Canada

pallavi123- September 29, 2021 0

Natco Pharma Limited has announced the Canadian launch of PrNAT-LENALIDOMIDE Capsules, a generic version of Celgene Corporation’s cancer drug Revlimid. The launch was announced earlier ... Read More

Vivimed Labs exports first shipment of Famotidine tablets to Canada

pallavi123- May 25, 2021 0

Vivimed Labs, an Indian pharma company, said that it has exported the first shipment of its Famotidine tablets 40mg and 20mg to Canada. Famotidine is ... Read More

Pfizer and BioNTech secure Health Canada approval for BNT162b2 Covid-19 vaccine

pharmanewsdaily- December 9, 2020 0

Pfizer, a leading global pharmaceutical company, and BioNTech, a prominent German biotech firm, have officially secured Health Canada's approval for their BNT162b2 vaccine. This approval, ... Read More